Sunrise Realty Trust stockholders approve merger-related stock issuance
Sunrise Realty Trust stockholders approve significant stock issuance for merger with Southern Realty Trust, alongside a prorated dividend announcement.
NOVAGOLD Resources updates shareholders on acquisition plans
NOVAGOLD Resources Inc. updates on its acquisition of a 40% interest in Donlin Gold LLC, aiming for 100% ownership and impacting the gold and silver ores sector.
Jewett Cameron Trading Co. agrees to sell property for $5.9M
Jewett Cameron Trading Co. Ltd. has signed an agreement to sell a surplus property for $5.9 million, enhancing its financial position in the retail lumber sector.
Xtend AI Robotics announces preliminary revenue, new CEO
Xtend AI Robotics reports preliminary revenue of $24.5-$26.5 million and appoints Matt McGraw as CEO, signaling growth in the autonomous systems sector.
Neogen Corporation Amends Incentive Plan Following Approval
Neogen Corporation's shareholders approve an amended incentive plan, allowing for a wider range of equity-based awards to boost employee engagement.
Hyperliquid Strategies boosts stock buyback program to $100M
Hyperliquid Strategies Inc increases its stock buyback program from $30 million to $100 million, extending the timeline through October 2027.
Peraso Inc. secures $10 million in private placement deal
Peraso Inc. has entered a $10 million private placement agreement with Nant Capital, allowing for strategic board appointments and financial growth.
Nathan's Famous Completes Merger with Smithfield Foods
Nathan's Famous, Inc. has merged with Smithfield Foods, becoming a wholly-owned subsidiary, impacting the retail-eating places industry.
Capstone Energy Plus appoints Brandon Schwertner to Board
Capstone Energy Plus, Inc. has appointed Brandon Schwertner to its Board of Directors, enhancing leadership as it aims for growth in the energy sector.
Bank of Hawaii reports solid Q3 results, boosts buyback program
Bank of Hawaii Corp announces Q3 earnings of $1.49 per share and increases share repurchase program by $200 million, reflecting strong financial performance.
LiveWire Group Announces CEO Resignation, Board Changes
LiveWire Group, Inc. announces CEO resignation and new board appointments as part of a strategic restructuring effort.
Empery Digital Resumes Stock Buyback Program Amid Updates
Empery Digital Inc. resumes its stock repurchase program and announces plans for an AI data center investment, signaling a strategic shift in capital allocation.
Business First Bancshares announces Q3 results and dividends
Business First Bancshares reports strong Q3 results with increased net income and dividends, reflecting growth in the state commercial banking sector.
SHF Holdings announces potential merger with Opifex Media
SHF Holdings, Inc. reveals a potential business combination with Opifex Media Inc., a significant move in the finance services sector.
K&F Growth Acquisition Corp. II Issues Class A Shares
K&F Growth Acquisition Corp. II has issued 9,583,332 Class A shares, moving towards a business combination and impacting the blank check industry.
Medifast Reports Third Quarter Earnings Decline Amid Challenges
Medifast, Inc. faces a revenue drop in Q3 2026, driven by fewer active coaches and market pressures, as it aims for profitability in the next quarter.
Valion Bio Receives Acquisition Interest for Velocity Bioworks
Valion Bio, Inc. announces unsolicited acquisition interest in its Velocity Bioworks subsidiary, evaluating strategic options for growth and development.
SpaceX Enters $40 Billion Finance Lease with Apollo Management
SpaceX has entered a master finance lease with Apollo Global Management for $40 billion, aimed at enhancing its data center capabilities.
Oruka Therapeutics reports positive Phase 2b trial results
Oruka Therapeutics announces encouraging results from its Phase 2b trial of ORKA-001 for psoriasis, paving the way for Phase 3 trials in 2027.
Zeo ScientifiX Partners with Pluri to Expand Manufacturing
Zeo ScientifiX announces a strategic partnership with Pluri Inc. to enhance U.S. manufacturing and commercialization in regenerative medicine and aesthetics.